Analyzing the U.S. Contribution to Global Health Initiatives
As the leading donor in global health, the U.S. government allocates its budget across several critical program areas, including HIV, tuberculosis, and malaria.
Editorial Staff Apr 21
Purdue Pharma's $225 Million Forfeiture Paves the Way for Settlement Finalization
A judge is anticipated to impose a $225 million forfeiture on Purdue Pharma, the maker of OxyContin, facilitating the completion of its settlement with the Justice Department.
Editorial Staff Apr 21
Purdue Pharma to Forfeit $225 Million in Settlement with Justice Department
A U.S. judge is anticipated to order Purdue Pharma to forfeit $225 million, marking a significant step in ongoing legal proceedings.
Editorial Staff Apr 21
Changes to CDC Conference Accessibility Raise Concerns
Recent developments indicate that a CDC conference, previously open to the public, may now have restricted access. This follows a federal ruling related to gender declaration and highlights ongoing issues in health policy.
Editorial Staff Apr 21
KFF Launches New Podcast to Navigate Health Policy and Business
KFF is set to debut a podcast hosted by Chip Kahn, focusing on the intricate relationship between health policy and business. The initiative aims to deepen understanding of these complexities.
Editorial Staff Apr 21
Rethinking the U.S. Health Care System: A Look Backward
The current U.S. health care system appears to prioritize retrospective evaluations, questioning the justification of past medical decisions.
Editorial Staff Apr 21
Examining the Impact of Trump's Executive Actions on LGBTQ+ Health
This analysis explores the Executive Actions from the Trump administration that may affect the health of LGBTQ+ individuals, detailing their potential implications.
Editorial Staff Apr 21
Daily Probiotics May Enhance Skin Health in Dogs, Study Suggests
Research from Adelaide University indicates that daily probiotic supplementation could improve gut and skin health in dogs, potentially reducing skin infections.
Editorial Staff Apr 21
New Protein Engineering Technique Could Enhance Cancer Treatment Precision
Recent advancements in protein engineering may improve cancer therapies. Proteases, enzymes that act as molecular scissors, are crucial in developing treatments that target both viral replication and cancer cell destruction.
Editorial Staff Apr 20
Understanding the Ongoing Battle Over Drug Price Transparency
A closer look at the ongoing disputes surrounding drug price transparency and the role of pharmacy benefit managers (PBMs) in this contentious issue.
Editorial Staff Apr 20
Advancements in Targeting KRAS: A New Era for Biotech
Recent developments highlight significant progress in targeting KRAS, a key player in cancer treatment, alongside other notable biotech news including the Breakthrough Prize winners.
Editorial Staff Apr 20
Trump Advocates for Psychedelic Treatments and Weight-Loss Drug Developments
In recent pharmaceutical news, Trump has shown support for psychedelic treatment options while discussions continue regarding the future of weight-loss drugs.
Editorial Staff Apr 20
Exploring the Impact of Cannabis on Young Minds
Recent discussions highlight the effects of cannabis on adolescent brain development, alongside updates on the CDC director nominee and a measles outbreak.
Editorial Staff Apr 20
Nektar Therapeutics Drug Shows Potential for Alopecia Treatment
Recent findings suggest that prolonged use of a drug from Nektar Therapeutics may encourage hair growth in individuals suffering from alopecia.
Editorial Staff Apr 20
Pharmacy Benefit Managers Challenge Trump's Drug Price Transparency Proposal
Pharmacy benefit managers (PBMs) are opposing a significant proposal aimed at increasing transparency in drug pricing, claiming it may be illegal.
Editorial Staff Apr 20
Insights from AACR 2026: Progress in KRAS Drug Development by Revolution Medicines
The American Association of Cancer Researchers' annual meeting showcases significant advancements in the development of KRAS-targeting therapies, particularly by Revolution Medicines.
Editorial Staff Apr 19
Navigating Early Retirement: The $47,000 Healthcare Challenge at 62
Early retirement at 62 can be appealing, but it comes with significant financial considerations, including a $47,000 healthcare gap before Medicare starts.
Editorial Staff Apr 19
Zai Lab and Amgen Collaborate on Lung Cancer Therapy Evaluation
Zai Lab and Amgen have announced a partnership to evaluate a new approach to lung cancer treatment, marking a significant step in cancer research.
Editorial Staff Apr 19
Ultragenyx's Gene Therapy for Sanfilippo Syndrome Receives FDA Acceptance
The FDA has accepted Ultragenyx's Biologics License Application for its gene therapy UX111, aimed at treating Sanfilippo Syndrome.
Editorial Staff Apr 19
Medicare Advantage Spending in Puerto Rico Rises by $865 Million Without Improvement in Plans
Despite a notable increase in Medicare Advantage spending in Puerto Rico, the expected improvements in plan quality have not materialized.
Editorial Staff Apr 19